Dose escalation phase (titration) Tirzepatide titration (dose escalation) typically follows this schedule: Month 2: 4-6 mg once weekly Month 3: 6-8 mg once weekly Month 4: If tolerated, increase to 8-10 mg once weekly Month 5: If the dosage needs to be escalated further, increase to 10-12 mg once weekly Month 6 and onward: If the dosage needs to be escalated further, increase to 12-14 mg once weekly The maximum dosage is typically 14 mg once weekly if further glycemic control or weight loss is required
It carries an expiry date, and an opened vial has a limited in-use period
For a visual walk-through, see the reconstitution guide
Notice that 40 units at 20 mg/mL delivers 8 mg of tirzepatide , not the 4 mg you would get at 10 mg/mL
Systemic Anti-Inflammatory Effects BPC-157 appears to modulate inflammatory pathways broadly, potentially reducing systemic inflammation that contributes to chronic pain, slow healing, and general wellness decline
However, this study is available only as an abstract, and its reliability is largely unknown
